Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Immunovant Inc (IMVT)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 87,080,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases. Co.'s compound, batoclimab, is a human, monoclonal antibody targeting the neonatal fragment crystallizable receptor. Co.'s product candidate, batoclimab, has been dosed in small volumes (e.g., two mL) and with a 27-gauge needle, while still generating therapeutically relevant pharmacodynamic activity. Co. is developing batoclimab for Myasthenia Gravis, Thyroid Eye Disease and Warm Autoimmune Hemolytic Anemia.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 1,526,316 1,977,983
Total Buy Value $0 $0 $58,000,008 $60,700,210
Total People Bought 0 0 1 3
Total Buy Transactions 0 0 1 4
Total Shares Sold 45,562 126,183 408,892 570,752
Total Sell Value $1,622,821 $4,598,288 $10,797,529 $13,241,467
Total People Sold 6 9 9 9
Total Sell Transactions 10 23 40 66
End Date 2024-01-21 2023-10-20 2023-04-21 2022-04-21

   
Records found: 182
  Page 1 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Butchko Julia G. Chief Development Officer   •       –      –    2024-04-17 4 S $28.80 $293,923 D/D (10,115) 451,627     -
   Barnett Eva Renee Chief Financial Officer   •       –      –    2024-04-17 4 S $28.80 $356,049 D/D (12,253) 359,456     -
   Macias William L. Chief Medical Officer   •       –      –    2024-04-17 4 S $28.80 $240,602 D/D (8,280) 377,650     -
   Salzmann Peter Chief Executive Officer   •       •      –    2024-04-17 4 S $28.80 $990,269 D/D (34,079) 1,052,879     -
   Levine Mark S. Chief Legal Officer   •       –      –    2024-04-17 4 S $28.80 $285,554 D/D (9,827) 347,119     -
   Salzmann Peter Chief Executive Officer   •       •      –    2024-04-09 4 S $31.18 $149,882 D/D (4,807) 1,086,958     -
   Butchko Julia G. Chief Development Officer   •       –      –    2024-04-09 4 S $31.18 $32,833 D/D (1,053) 461,742     -
   Barnett Eva Renee Chief Financial Officer   •       –      –    2024-04-09 4 S $31.18 $115,023 D/D (3,689) 371,709     -
   Butchko Julia G. Chief Development Officer   •       –      –    2024-04-02 4 A $0.00 $0 D/D 54,978 462,795     -
   Geffner Michael Chief Medical Officer   •       –      –    2024-04-02 4 A $0.00 $0 D/D 54,978 144,877     -
   Salzmann Peter Chief Executive Officer   •       •      –    2024-04-02 4 A $0.00 $0 D/D 160,534 1,091,765     -
   Pande Atul Director   –       •      –    2024-04-02 4 A $0.00 $0 D/D 11,255 94,413     -
   Levine Mark S. Chief Legal Officer   •       –      –    2024-04-02 4 A $0.00 $0 D/D 54,978 356,946     -
   Torti Frank Director   –       •      –    2024-04-02 4 A $0.00 $0 D/D 120,400 635,674     -
   Migausky George V Director   –       •      –    2024-04-02 4 A $0.00 $0 D/D 11,255 121,063     -
   Hughes Douglas J. Director   –       •      –    2024-04-02 4 A $0.00 $0 D/D 11,255 125,010     -
   Barnett Eva Renee Chief Financial Officer   •       –      –    2024-04-02 4 A $0.00 $0 D/D 54,978 375,398     -
   Fromkin Drew J Director   –       •      –    2024-04-02 4 A $0.00 $0 D/D 11,255 99,913     -
   Macias William L. Chief Medical Officer   •       –      –    2024-04-02 4 A $0.00 $0 D/D 54,978 385,930     -
   Stout Jay S Chief Technology Officer   •       –      –    2024-04-02 4 A $0.00 $0 D/D 54,978 154,978     -
   Barnett Eva Renee Chief Financial Officer   •       –      –    2024-02-22 4 S $36.15 $105,920 D/D (2,930) 320,420     -
   Salzmann Peter Chief Executive Officer   •       •      –    2024-02-22 4 S $36.15 $486,362 D/D (13,454) 931,231     -
   Macias William L. Chief Medical Officer   •       –      –    2024-02-22 4 S $36.15 $80,289 D/D (2,221) 330,952     -
   Levine Mark S. Chief Legal Officer   •       –      –    2024-02-22 4 S $36.15 $77,144 D/D (2,134) 301,968     -
   Butchko Julia G. Chief Development Officer   •       –      –    2024-02-22 4 S $36.15 $77,578 D/D (2,146) 407,817     -
  182 Records found
  1  2  3  4  5  6  7  8   
  Page 1 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us